Project Grant HT94252410832
Award Date 8/1/24
Completion Date 7/31/27
Dollars Obligated $1.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Irwindale, CA 91010, USA
Similar Awards
- This federal Project Grant award of $144,018.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support the Beckman Research Institute of the City of Hope in conducting a telehealth intervention to impact quality of life and pancreatic cancer survivorship. The award period runs from August 1, 2024 to July 31, 2027. The Project Grant aims to develop and evaluate a telehealth-based intervention to improve outcomes for pancreatic...
- The Defense Health Agency (DHA) awarded a $999,997 project grant under the Military Medical Research and Development (CFDA 12.420) program to the Beckman Research Institute of the City of Hope for the "PERIOPERATIVE OSTOMY SELF-MANAGEMENT TELEHEALTH INTERVENTION FOR CANCER SURVIVORS" project. The grant, awarded on September 15, 2024, will fund research to develop a telehealth intervention to support self-management for cancer survivors with ostomies. As a nonprofit medical research...
- The Defense Health Agency awarded a $5,339,958 project grant to the Beckman Research Institute of the City of Hope for the "Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor-T Cell Therapy" initiative. This award falls under the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The project aims...
- The Defense Health Agency awarded a $1,319,487 Project Grant to the Beckman Research Institute of the City of Hope, located in Irwindale, CA, under the Military Medical Research and Development program (CFDA 12.420). The grant, with a period of performance from September 15, 2025 to September 14, 2029, will support research aimed at "Targeting Diabetes-Associated Radioresistance to Improve Prostate Cancer Control and Quality-of-Life Outcomes." The Beckman Research Institute, a...
- The Department of Defense's Defense Health Agency awarded a $845,928 Project Grant to The Trustees of Columbia University in the City of New York, Health Sciences Division, to support the "ENHANCING EARLY DETECTION OF PANCREATIC CANCER USING GPT-EMBEDDED EHR MODELS: A NOVEL APPROACH FOR IMPROVED PREDICTIVE PERFORMANCE AND INTERPRETABILITY" research project. This grant, funded through the Military Medical Research and Development program (CFDA 12.420), will focus on developing...
- This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, provides $301,000.00 to the University of Miami to develop an eHealth psychosocial stress and symptom management intervention for patients with pancreatic cancer. The project aims to transform healthcare for military service members and the broader public by investigating innovative approaches to disease prevention, diagnosis, treatment, and management....
- This Project Grant award of $1,759,998.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the Beckman Research Institute of the City of Hope to potentiate T cell activity against multiple myeloma through inhibition of sumoylation. The research aims to transform healthcare for Service Members and the American public through innovative and impactful work. The award term runs from Aug 1, 2023 to Jul 31, 2026. As a...
- The Department of Defense's Defense Health Agency awarded a $447,612 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Beckman Research Institute of the City of Hope. The grant supports the development of a "highly tumor-specific oncolytic virus in combination with a viral protein-target T cell engager for the treatment of triple-negative breast cancer." The award period runs from January 1, 2024 to December 31, 2026. As a nonprofit...
- This Project Grant award, valued at $590,625.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of California, Los Angeles (UCLA) for a pilot study on dual immunotherapy in combination with chemotherapy for patients with pancreatic adenocarcinoma. The award, with a period of performance from September 1, 2025 to August 31, 2028, will support research to investigate the immune mechanisms of resistance to this...
- This $615,999 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Beckman Research Institute of the City of Hope, a nonprofit organization. The grant funds research to develop a "Targeted Telomere-Disrupting Oligonucleotide for Acute Myeloid Leukemia Therapy" over a 3-year period from Sep 1, 2023 to Aug 31, 2026. As a nonprofit research organization, Beckman Research Institute leverages its medical...